BRANDON STUART IMBER
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology NEW YORK, NY NPI 1275928871
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology NY NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$16,833.53
- Category: General Payments
- Program years: PY2021–2024
- Record count: 21
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,133.09 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $841.55 | 7 |
| Travel and Lodging | $291.54 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,021.52 | 5 |
| Telix Pharmaceuticals | $96.52 | 2 |
| Tempus AI, Inc | $15.05 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1081983258 | Telix Pharmaceuticals | $33.53 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1081983260 | Telix Pharmaceuticals | $62.99 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086921261 | Novartis Pharmaceuticals Corporation | $291.54 | 05/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1086921275 | Novartis Pharmaceuticals Corporation | $139.99 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086921277 | Novartis Pharmaceuticals Corporation | $225.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086921279 | Novartis Pharmaceuticals Corporation | $139.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086921281 | Novartis Pharmaceuticals Corporation | $225.00 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150166634 | Tempus AI, Inc | $15.05 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.